Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grat...
structured reports in radiology
Therapy Response Assessment
with RECIST 1.1
and many more
Select your job-to-be-done from already
implemented reading profiles
Create your own reading profile customized
for your specific job-to-be-done
Therapy Response Evaluation
- Colon / Rectum
- Stomach / Esophagus
- Head / Neck
- Prostate | PI-RADS
- Liver | LI-RADS
- RECIST 1.1
- RESIT 1.0
- mRECIST HCC
- mRECIST Mesothelioma
- RANO / RANO-BM
- RECIST 1.1 / iRECIST
- Customizable Profiles
Dr. Daniele ReggeCandiolo Cancer Institute Turin
PD Dr. Thorsten PersigehlUniversity Hospital Cologne
Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.Prof. Dr. Dominik FleischmannStanford University
Prof. Dr. Elmar KotterUniversity Hospital Freiburg
Prof. Dr. Georg BongartzUniversity Hospital Basel
Prof. Dr. Marika GantenGerman Cancer Research Center
Prof. Dr. Philippe PereiraSLK Clinics Heilbronn
Prof. Dr. Werner JaschkeUniversity Hospital Innsbruck
Ensure compliance with
oncological screening, staging, and
response assessment guidelines.
Simplify and streamline your
read process and reduce open questions
with generated results.
Reproducibly document all
radiological reads; communicate and
archive your findings.
Benefit from context driven
read workflows skimming all relevant
information for a holistic report.
Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imagingIn News
In the first week of March, we will make the relevant software functions available for all our c...
The radiology report is expected to provide information that impacts life changing treatment dec...
In randomized controlled trials (RCTs), a vast proportion of patients does not meet the precise ...